Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
QL is the guarantor of this work and, as such, has full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis
Keep all receipts and prescription documentation for your records
In our clinical trial in patients with #obesity and cardiovascular risk, 75% of patients treated with NT-0796, NodThera's oral, small molecule, brain-penetrant #NLRP3 inflammasome inhibitor, achieved a meaningful reduction in C-reactive protein, a key marker of #inflammatory diseases such as coronary artery disease
All authors approved the final version
US$ 27.44
US$ 28.26
US$ 27.28
